CHEN Yan-li, LI Li. Meta Analysis on Neoadjuvant Chemotherapy with Radical Surgery in Locally Advanced Cervical CancerJ. Journal of Evidence-Based Medicine, 2013, 13(4): 230-235. DOI: 10.3969/j.issn.1671-5144.2013.04.012
Citation:
CHEN Yan-li, LI Li. Meta Analysis on Neoadjuvant Chemotherapy with Radical Surgery in Locally Advanced Cervical CancerJ. Journal of Evidence-Based Medicine, 2013, 13(4): 230-235. DOI: 10.3969/j.issn.1671-5144.2013.04.012
CHEN Yan-li, LI Li. Meta Analysis on Neoadjuvant Chemotherapy with Radical Surgery in Locally Advanced Cervical CancerJ. Journal of Evidence-Based Medicine, 2013, 13(4): 230-235. DOI: 10.3969/j.issn.1671-5144.2013.04.012
Citation:
CHEN Yan-li, LI Li. Meta Analysis on Neoadjuvant Chemotherapy with Radical Surgery in Locally Advanced Cervical CancerJ. Journal of Evidence-Based Medicine, 2013, 13(4): 230-235. DOI: 10.3969/j.issn.1671-5144.2013.04.012
Meta Analysis on Neoadjuvant Chemotherapy with Radical Surgery in Locally Advanced Cervical Cancer
No content published by the Journal of Evidence-Based Medicine may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journal without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Journal of Evidence-Based Medicine’ Sponsors or the Editorial Board, unless this is clearly specified.
Objective To evaluate the clinical efficacy of neoadjuvant chemotherapy (NACT) and radical surgery(RS) in locally advanced cervical cancer. Methods The following electronic databases were searched: CBMdisc,MEDLNE, PubMed, EMBASE, Cochrane Library. All eligible documents were assessed for quality, and extracted data were performed by a meta-analysis. Results 5 articles met the inclusion criteria, among which were four prospective randomized controlled trials and one retrospective case-control study. NACT and RS did not increase the 5-year survival rate, but increased the 5-year disease-free survival rate and decreased lymph node metastasis and parameter metastasis. Conclusion NACT and RS could be chosen to treat the locally advanced cervical cancer. It increased the 5-year disease-free survival rate and decreased lymph node metastasis and parameter metastasis. But the conclusion is needed to be further assessed by rigorously designed, randomized, double-blind, controlled trials.